2012 · Nie et al. — Hydrogenase: the next antibiotic target?
Super-Abstract
Bacteria produce hydrogen gas (H₂) via enzymes called hydrogenases — and this review proposes that these enzymes, by generating H₂ which neutralizes bactericidal hydroxyl radicals, may actually help bacteria survive antibiotic treatment and evade immune defenses. If correct, inhibiting bacterial hydrogenases could become a new strategy for antibiotics. This is a review article that synthesizes existing knowledge and presents a speculative hypothesis — no new experiments are conducted.
Commentary
This review takes an interesting and counterintuitive perspective: while most H₂ biology research focuses on H₂ as beneficial to humans (as an antioxidant), this paper asks whether H₂ produced by bacteria helps those bacteria survive. The logic is mechanistically sound: bactericidal antibiotics and immune phagocytes both generate hydroxyl radicals (•OH) to kill bacteria, and if bacterial hydrogenases produce enough H₂ to neutralize these •OH radicals, bacteria gain a survival advantage. The authors argue this could contribute to antibiotic resistance and virulence. This is a hypothesis review, not an experimental proof. The speculation is scientifically interesting but requires experimental validation. Notably, this mechanism — if real — would not diminish the human health benefits of H₂ therapy, since the contexts (bacterial intracellular H₂ vs. exogenous H₂ supplementation in humans) are quite different.
Key quotes
- „H2 is a potent antioxidant and can selectively neutralize OH• (hydroxyl radicals).“ — the established H₂ mechanism that underpins the hypothesis
- „OH•, however, has been implicated as one of the mechanisms whereby bactericidal antibiotics and professional phagocytes kill bacteria.“ — the key link: hydroxyl radicals are the bacteria-killing weapon
- „we have enough reason to speculate that hydrogenases and H2 are conducive to increasing the virulence and antibiotic resistance of bacteria, and hydrogenase inhibitors would help control bacterial infection.“ — the core hypothesis — explicitly presented as speculation by the authors
Our assessment
This is a review paper presenting a speculative hypothesis — no new experimental data are generated. The idea that bacterial hydrogenases could be antibiotic targets is scientifically interesting and mechanistically plausible, but remains unproven. The authors appropriately use cautious language („we speculate"). This paper does not concern H₂ therapy for humans — it addresses a potential bacterial defense mechanism. The hypothesis would need experimental validation (e.g., hydrogenase knockout bacteria, animal infection models) before any clinical or therapeutic conclusions could be drawn.
Study design
- Type: narrative review / hypothesis paper · n: n/a (literature analysis, no experiments) · H₂ relevance: bacterial H₂ production by hydrogenases as a putative antibiotic-resistance mechanism
- Result: no experimental data; hypothesis that bacterial hydrogenases + H₂ neutralize bactericidal •OH radicals, thereby promoting antibiotic resistance and virulence; hydrogenase inhibition proposed as potential new antibiotic strategy
Abstract
The struggle to control infectious diseases has become increasingly difficult due to resistance to current antibiotics and the co-existence of multiplying and non-multiplying bacteria, which makes it an urgent task to discover new antibiotic targets and to develop new antibiotics. Hydrogenases are found in micro-organisms belonging to the archaea and bacteria domains, which can catalyse the reversible oxidation of hydrogen gas (H2↔2H⁺ +2e) and play pleiotropic roles in microbial survival. Studies have shown that H2 is a potent antioxidant and can selectively neutralize OH• (hydroxyl radicals). OH•, however, has been implicated as one of the mechanisms whereby bactericidal antibiotics and professional phagocytes kill bacteria. Thus we have enough reason to speculate that hydrogenases and H2 are conducive to increasing the virulence and antibiotic resistance of bacteria, and hydrogenase inhibitors would help control bacterial infection.
Source & links
Screenshot of the PubMed page
This page mirrors the published abstract (© the authors / publisher) for reference and citation. The canonical source is the PubMed record linked above. This is not medical advice.